This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022): „New generation bioactive molecules delivery systems, based on chemically synthesized and obtained through genetic engineering” is dedicated to the construction of several classes of novel bionanoparticles fused with concatemeric proteins, based on DNA-FACE™.
top of page
Recent news
Archived news
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022): „New generation bioactive molecules delivery systems, based on chemically synthesized and obtained through genetic engineering” is dedicated to the construction of several classes of novel bionanoparticles fused with concatemeric proteins, based on DNA-FACE™.
The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The PL 240667 patent is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development STRATEGMED1/235077/9/NCBR/2014 (2014-2017): “Novel technologies for pharmacological stimulation of regeneration.”
bottom of page